| DSM 10068| Sporobacter termitidis| Sporobacter termitidis Grech-Mora et al. 1996| strain SYR| Termitobacter aceticus
Gut symbiosis: Sporobacter termitidis is considered part of the normal gut microbiota of termites and plays a symbiotic role in the digestion of cellulose and other complex carbohydrates found in wood. These bacteria produce enzymes that aid in the breakdown of cellulose into simpler sugars, which can then be metabolized by both the insect and the bacteria. This symbiotic relationship is essential for the survival and nutrition of termites, allowing them to efficiently extract nutrients from their wood-based diet.
Biodegradation: Sporobacter termitidis and other gut bacteria of termites are involved in the biodegradation of lignocellulosic biomass, such as wood, leaf litter, and plant debris. Their enzymatic activities contribute to the decomposition of organic matter in the environment, which is important for nutrient cycling and ecosystem functioning. While this process is beneficial for natural ecosystems, it is not directly related to human health impacts.
Potential biotechnological applications: The cellulolytic and lignocellulolytic capabilities of Sporobacter termitidis and related bacteria have attracted interest for potential biotechnological applications, particularly in the bioconversion of lignocellulosic biomass into biofuels and other value-added products. Understanding the enzymatic machinery and metabolic pathways of these bacteria may inform the development of more efficient bioprocessing technologies for biomass conversion.
Environmental health: Sporobacter termitidis and other termite gut bacteria contribute to the decomposition of organic matter in terrestrial ecosystems, which has implications for soil fertility, carbon sequestration, and ecosystem resilience. While these processes are important for environmental health, they are not directly linked to human health impacts.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.57 | 6 | 17400 | 0 | 11814 | 2447.9 | 114 | 4778.8 | 6 | 17400 | 6.7 %ile | 86.7 %ile | ||
thryve | 91.79 | 4514 | 60 | 5107 | 0 | 24083 | 3541.8 | 847 | 10480.1 | 0 | 6373 | 11.5 %ile | 90.6 %ile | |
ubiome | 2.53 | 23 | 162 | 0 | 142 | 59.7 | 46 | 41.9 | 15 | 95 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSightRdp | 29.032 % | 0.452 % | 0.52 % | 9.0 | 31 |
custom | 4.918 % | 0.194 % | 0.07 % | 3.0 | 61 |
Medivere | 85.714 % | 0.004 % | 0.004 % | 6.0 | 7 |
Thryve | 92.518 % | 0.376 % | 0.998 % | 1286.0 | 1390 |
uBiome | 2.652 % | 0.006 % | 0.004 % | 21.0 | 792 |
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.